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In a population of 56,242 individuals living in France, we showed that individuals born
in France have significantly different levels of blood pressure (BP) and cardiovascular
(CV) risk factors than African and Asian populations born in their own country but
living long-term in France (average duration of stay, 5–10 years). The objective of our
study was to investigate the impact of country of birth on BP and CV risk factors in
a subpopulation of 9245 patients selected solely on the diagnosis of hypertension,
either alone or with simultaneous type 2 diabetes. In the subgroup of individuals with
hypertension alone, brachial systolic, diastolic, mean and pulse pressure (PP), heart rate
(HR), augmentation index and PP amplification were significantly higher in African-born
than French- and Asian-born populations. In the subgroup of individuals with both
hypertension and diabetes, only augmentation index, PP amplification and brachial and
central PP, but not brachial systolic, diastolic, mean BP, and HR, were elevated when
the African-born subgroup was compared to the French- and Asian-born populations.
Increased body mass index (BMI), waist-hip ratio (WHR), and deprivation scores, but not
increased plasma lipids or glycemia, were consistently associated with the African-born
population. The combination of diabetes and hypertension in African populations was
associated with increased aortic stiffness and PP, together with greater body weight and
WHR. In individuals with increased PP and hence systolic hypertension, increased PP
requires systolic BP to be reduced whereas notable reductions in diastolic BP may have
deleterious consequences.
Keywords: country of birth, hypertension, diabetes mellitus, aortic stiffness, wave reflection, ethnicity
Introduction
National health statistics and prospective epidemiological studies, mainly from the United States,
have consistently established that hypertensive cardiovascular (CV) disease, stroke, and coronary
heart disease are considerably more prevalent in black than in white populations, with a higher
prevalence of cardiac and renal failure in the black population (Chrysant et al., 1979; Dunn et al.,
1983; Nichols and O’Rourke, 2006; Carson et al., 2011; Chirinos et al., 2011; Frohlich, 2011). In a
more recent study in France (Thomas et al., 2012), age, blood pressure (BP), overweight, obesity,
Aoun Bahous et al. Country of birth affects BP
and diabetes mellitus were shown to be significant risk factors
associated with hypertension in individuals born in Africa,
although no striking evidence of CV or renal structure and
function impairments was found. In addition, the characteristic
CV profile of Asian-born populations was also an important
consideration, with lower body weight and HDL-cholesterol, and
higher HR and plasma triglyceride levels. It therefore appeared
important to determine the impact of country of birth on the CV
risk-profile of French-, African- and Asian-born subgroups all
residing long-term in France. Thus, the primary objective of the
present study was to determine the hemodynamic and metabolic
characteristics of three groups of individuals, all living in France
on a long-term basis, but born in three different geographical
localities: France, Africa, and Asia.
Effective CV prevention requires multiple risk factors to be
addressed simultaneously in order to achieve the most significant
reduction in morbidity and mortality in a given population
(Safar et al., 2013). In particular, both hypertension and diabetes
mellitus are major risk factors for CV diseases. Although
interesting results were obtained on this subject in a multi-ethnic
study of atherosclerosis (Carson et al., 2011), to date, little has
been studied in large populations on the possible consequences
of combined chronic treatment of hypertension and type 2
diabetes. This is nevertheless an important consideration because
approximately 50% of diabetic individuals have hypertension
and 20% of hypertensive patients also have diabetes mellitus
(Safar et al., 2013). It therefore appeared useful to investigate
how country of birth can affect the presence and potential
combination of hypertension and type 2 diabetes. This is a
particularly important goal of the present study.
Epidemiological studies in hypertension and diabetes mellitus
have shown that factors other than high BP play a significant role
in CV morbidity and mortality. These include the conventional
risk factors of both diseases, and in particular, the role of gender
and the degree of obesity (Egan et al., 2010; Regnault et al., 2012).
Assessing these factors was therefore another major objective of
this report.
Our study involved three different steps: (1) to define the
impact of country of birth (France, country of the African
continent, country of the Asian continent) on the hemodynamic
and metabolic characteristics of individuals all living in France
on a long-term basis; (2) to define the impact of country of
birth in the same populations according to the presence of two
associated CV risk factors, hypertension and type II diabetes;
(3) to determine the factors affecting hypertension according
to other specific characteristics of the country of birth, and in
particular, the degree of obesity.
TABLE 1 | Prevalence of hypertension (N, %) and diabetes (N, %) in the overall population (men and women) according to country of birth (Asian country,
African country, or France).
No hypertension and Hypertension and Diabetes and Diabetes and
no diabetes no diabetes no hypertension hypertension
Asia (N = 3171) Men/Women 2297 (72.4%) 1126/1171 625 (19.7%) 362/263 117 (3.7%) 74/43 132 (4.2%) 78/54
Africa (N = 13,485) Men/Women 9183 (68.1%) 4915/4268 3315 (24.6%) 2030/1285 386 (2.9%) 244/142 600 (4.4%) 367/233
France (N = 26,925) Men/Women 20,994 (78.0%) 12,044/8950 5305 (19.7%) 3498/1807 219 (0.8%) 143/76 407 (1.8%) 284/123
Population and Methods
The Clinical and preventive investigation Centers (IPC,
Investigations Préventives et Cliniques) propose a complementary
medical examination subsidized by the French national
healthcare system (Social Security-CNAMTS), once every 5 years
to all working and retired individuals and their families, living
in Paris and its suburbs. Approximately 25 000 examinations
are conducted annually. This therefore provides a large
heterogeneous population of adults of both sexes and enables
assessment of three populations, as determined by country of
birth: country of the African continent, country of the Asian
continent, and France.
Our study sample comprises all individuals (N = 56,242) who
had a standard health checkup at the IPC Center in Paris between
January 2008 and December 2011. Country or continent of birth
was ascertained from responses to a self-reported questionnaire,
coded by a person with experience in data-collection (Table 1).
Of the total population, 57.2% of the men and 51.7% of the
women were born in France, 26.9% (men) and 28.0% (women)
in African countries (including North Africa), and 5.8% (men)
and 7.1% (women) in Asia. Study participants who were born
in either Africa or Asia, reported having been resident in France
for between 5 and 10 years. The remainder reported countries
of birth as other European, American, Pacific, or Caribbean
countries, but the number of individuals in each subgroup was
insufficient for analysis. Mean age of participants was 43.3 ±
13.8 years (men, 43.6 ± 12.8; women, 43.0 ± 15.0) and was
comparable between the three main categories of country of birth
(Tables 2–4).
BP was measured three times in the right arm using a
semi-automatic electronic device (Omron 705-CP-II, Rosny-
sous-Bois, France) with the patient in the supine position after
a 10-min period of rest (Nichols and O’Rourke, 2006); the
BP value retained was the average of the three measurements.
Brachial pulse pressure (PP) [PP = systolic BP (SBP) – diastolic
BP (DBP)] and mean BP (MBP = DBP + 1/3 brachial PP)
were also calculated. Central (carotid) PP (CPP) was estimated
according to gender using the equation validated in a previous
personal study (Thomas et al., 2012; Safar et al., 2013). Carotid
augmentation index (CAI), the currently used index to describe
the relative increase in central BP due to pressure wave reflections
(magnitude and timing), was also estimated using the equations
proposed by Chirinos et al., to account for the role of ethnic
differences in supine BP measurements (Chirinos et al., 2011).
Pulse pressure (PP) amplification was calculated as the CPP/BPP
ratio. There were no direct measurements of cardiac function.
Frontiers in Physiology | www.frontiersin.org 2 September 2015 | Volume 6 | Article 248
Aoun Bahous et al. Country of birth affects BP
TABLE 2 | Main characteristics (with standard deviation) of the entire
population (N = 56,242 men and women) according to country of birth.
Asia Africa France
N 3171 13,484 26,925
Age (years) 44.27 (12.3) 43.80 (13.5) 42.90 (14.0)
Brachial SBP (mm Hg) 125.8 (0.36) 129.6 (0.2)*** 126.3 (0.1)
Brachial DBP (mm Hg) 76.6 (0.2)*** 77.9 (0.1)*** 75.6 (0.1)
Brachial MBP (mm Hg) 93.0 (0.2)* 95.1 (0.1)*** 92.5 (0.1)
Brachial PP (mm Hg) 49.2 (0.2)*** 51.7 (0.1)*** 50.7 (0.1)
Central PP (mm Hg) 35.9 (0.2)*** 37.9 (0.1)*** 37.0 (0.1)
Heart rate (bpm) 65.6 (0.2)*** 65.0 (0.1)*** 62.4 (0.07)
CAI (%) 125.9 (0.1)*** 131.4 (0.07)*** 125.0 (0.05)
PP Amplification (%) 0.726 (0.001)* 0.731 (0.0004)*** 0.728 (0.0003)
BMI (kg/m2) 24.8 (0.08) 26.4 (0.04)*** 24.7 (0.03)
WHR 0.877 (0.001)*** 0.869 (0.0006)*** 0.856 (0.0004)
TC (mg/dL) 201.3 (0.7)** 195.4 (0.3)*** 203.6 (0.2)
HDL-C (mg/dL) 49.3 (0.2)*** 50.5 (0.1)*** 54.2 (0.08)
TG (mg/dL) 120.1 (1.2)*** 98.8 (0.6)* 97.3 (0.4)
Glycemia (mg/dL) 100.1 (0.3)*** 98.5 (0.2)*** 96.6 (0.1)
GAMMA-GT (UI/L) 33.9 (1.0) 34.7 (0.5) 33.6 (0.3)
TT for hypertension (%, N) 5.95 (190) 7.79 (1061) 4.89 (1324)
TT for diabetes (%, N) 4.86 (155) 4.60 (626) 1.02 (277)
TT for cholesterol 7.30 (233) 4.65 (633) 4.87 (1319)
EPICE score 38.7 (0.4)*** 44.4 (0.2)*** 23.4 (0.1)
*P < 0.05 vs. France; **P < 0.01 vs. France; ***P < 0.0001 vs. France.
SBP, Systolic blood pressure; DBP, Diastolic blood pressure; MBP, Mean blood pressure;
Brachial PP, Brachial pulse pressure; Central PP, Central pulse pressure; CAI, Carotid
augmentation index; BMI, Body mass index; WHR, Waist-Hip ratio; TC, Total cholesterol;
HDL-C, HDL-cholesterol; TG, triglycerides; TT, treatment; EPICE score, Evaluation of
Precariousness and Inequalities in Health Examination Centers Score.
Waist circumference was measured with a non-elastic tape
placed midway between the lower rib cage and the iliac
crests on the mid-axillary line, with the patient in the
standing position; hip circumference was measured at the
maximum protuberance of the buttocks. Waist-hip ratio (WHR)
was calculated. Standard biological parameters [automated
enzymatic method, HITACHI 917 (Roche, Meylan, France);
colorimetric method for albumin dosage and hematology, ABX,
Pentra 120 (Meylan, France)] were measured under fasting
conditions (Thomas et al., 2012; Safar et al., 2013). High-density
lipoprotein (HDL)-cholesterol concentrations were calculated by
direct enzymatic assay with cyclodextrin (Roche Diagnostics,
Basel, Switzerland). Biological analyses (total cholesterol, HDL-
cholesterol, triglycerides, glycemia, and Gamma-GT) and clinical
parameters [brachial BP, central BP, heart rate (HR), CAI,
PP, body mass index (BMI), and WHR] were assessed on
the same day as the checkup. HR was determined with a
resting electrocardiogram. Information on country of birth,
tobacco consumption, physical activity, personal medical history,
social and economic deprivation status, assessed with the
EPICES (Evaluation of Precariousness and Inequalities in
Health Examination Centers) score (Thomas et al., 2012),
and current medications was obtained from the self-reported
questionnaire.
TABLE 3 | Main characteristics (with standard deviation) of individuals
with hypertension without diabetes (men and women) according to
country of birth.
Asia Africa France
N 625 3315 5305
Age (years) 52.3 (11.5) 51.0 (12.5) 52.7 (13.8)
Brachial SBP (mm Hg) 148.8 (0.59) 151.1 (0.25)*** 148.3 (0.2)
Brachial DBP (mm Hg) 88.2 (0.4)* 89.1 (0.2)*** 87.0 (0.1)
Brachial MBP (mm Hg) 108.4 (0.4)* 109.9 (0.2)*** 107.5 (0.1)
Brachial PP (mm Hg) 60.6 (0.5) 62.0 (0.2)** 61.1 (0.2)
Central PP (mm Hg) 46.3 (0.4) 47.5 (0.2)*** 46.5 (0.1)
Heart rate (bpm) 68.3 (0.5)*** 67.1 (0.2)** 66.1 (0.1)
CAI (%) 129.5 (0.5)*** 135.9 (0.2)*** 131.0 (0.1)
PP Amplification (%) 0.757 (0.003) 0.760 (0.001)*** 0.754 (0.001)
BMI (kg/m2) 26.6 (0.2) 27.9 (0.09)*** 26.9 (0.07)
WHR 0.91 (0.003)*** 0.90 (0.001)* 0.89 (0.001)
TC (mg/dL) 212.2 (1.6)*** 207.2 (0.7)*** 218.6 (0.5)
HDL-C (mg/dL) 48.5 (0.6)*** 51.2 (0.2)*** 54.9 (0.20)
TG (mg/dL) 138.0 (2.9)*** 109.2 (1.3)*** 116.3 (1.0)
Glycemia (mg/dL) 99.2 (0.4) 97.6 (0.2)*** 99.5 (0.1)
GAMMA-GT (UI/L) 44.4 (3.4) 42.9 (1.5)** 48.9 (1.2)
EPICE score 41.2 (0.9)*** 46.1 (0.4)*** 24.1 (0.3)
*P < 0.05 vs. France; **P < 0.01 vs. France; ***P < 0.0001 vs. France.
SBP, Systolic blood pressure; DBP, Diastolic blood pressure; MBP, Mean blood pressure;
Brachial PP, Brachial pulse pressure; Central PP, Central pulse pressure; CAI, Carotid
augmentation index; BMI, Body mass index; WHR, Waist-Hip ratio; TC, Total cholesterol;
HDL-C, HDL cholesterol; TG, triglycerides; EPICE score, Evaluation of Precariousness
and Inequalities in Health Examination Centers Score.
The IPC Center was given permission by the French
Data Protection Authority (CNIL, Commission Nationale de
l’Informatique et des Libertés) to conduct these analyses. All
participants provided written informed consent at the check-up.
Statistical Analysis
Hypertension was defined as brachial SBP ≥140mmHg and/or
DBP ≥90mmHg with or without antihypertensive drug therapy.
Diabetes was defined as fasting glucose ≥126mg/dL and/or
current specific hypoglycemic treatment.
Multiple variance analysis was used to compare groups
adjusted for age and gender. Multiple regression logistic models
were used to identify predictive factors of systolic hypertension
in each country of birth.
All statistical analyses were performed using the SAS statistical
software package (version 8.02; SAS Institute, Cary, NC, USA).
Results
The prevalence of hypertension and diabetes in both sexes
according to country of birth is presented in Table 1. The
prevalence of hypertension was higher among study participants
born in Africa and in Asia than in those born in France (France
vs. Africa, P < 0.0001; France vs. Asia, no difference; and Africa
vs. Asia, P < 0.001). The prevalence of diabetes was significantly
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TABLE 4 | Main characteristics (with standard deviation) of individuals
with hypertension and diabetes (men and women), according to country
of birth.
Asia Africa France
N 132 600 407
Age (years) 57.09 (10.0) 59.37 (9.9) 59.73 (10.9)
Brachial SBP (mm Hg) 149.8 (1.52) 152.1 (0.7) 150.6 (0.1)
Brachial DBP (mm Hg) 86.1 (0.9) 86.5 (0.4) 87.7 (0.5)
Brachial MBP (mm Hg) 107.3 (1.0) 108.3 (0.5) 108.7 (0.6)
Brachial PP (mm Hg) 63.7 (1.2) 65.6 (0.6)** 62.9 (0.7)
Central PP (mm Hg) 47.4 (1.5) 48.9 (0.5)* 46.6 (0.6)
Heart rate (bpm) 72.1 (1.40) 71.4 (0.6) 70.4 (0.7)
CAI (%) 130.0 (1.0)*** 137.3 (0.4)*** 134.7 (0.5)
PP Amplification (%) 0.738 (0.005) 0.742 (0.002)* 0.732 (0.003)
BMI (kg/m2) 27.5 (0.4)*** 29.9 (0.2) 30.3 (0.25)
WHR 0.97 (0.01)* 0.95 (0.002) 0.95 (0.004)
TC (mg/dL) 205.4 (4.0) 196.0 (1.8)*** 210.4 (2.2)
HDL-C (mg/dL) 45.6 (0.3)** 46.7 (0.5)*** 49.9 (0.6)
TG (mg/dL) 184.3 (8.6)** 142.2 (4.0)* 155.4 (4.9)
Glycemia (mg/dL) 153.7 (4.9) 153.3 (2.3) 150.8 (2.8)
GAMMA-GT (UI/L) 53.0 (10.1)* 54.7 (4.7)** 83.1 (5.8)
EPICE score 45.8 (2.0)*** 50.0 (0.9)*** 29.8 (1.1)
*P < 0.05 vs. France; **P < 0.01 vs. France; ***P < 0.0001 vs. France.
SBP, Systolic blood pressure; DBP, Diastolic blood pressure; MBP, Mean blood pressure;
Brachial PP, Brachial Pulse Pressure; Central PP, Central pulse pressure; CAI, Carotid
Augmentation index; BMI, Body mass index; WHR, Waist-Hip ratio; TC, Total cholesterol;
HDL-C, HDL-cholesterol; TG, triglycerides; EPICE score, Evaluation of Precariousness
and Inequalities in Health Examination Centers Score.
higher among participants born in Africa and Asia than in those
born in France (France vs. Africa, P < 0.0001; France vs. Asia,
P < 0.0001; Africa vs. Asia, NS). The proportion of participants
with both hypertension and diabetes was similar among those
who were born in Africa or Asia but considerably lower in those
born in France.
Table 2 shows the clinical and biological parameters according
to country of birth in the overall study population. Compared to
individuals born in France, those who were born in Africa had
higher brachial SBP, DBP, MBP, brachial and central PP, HR, CAI
and PP amplification, BMI, WHR, plasma glucose, triglycerides,
and EPICES scores. In contrast, HDL-cholesterol and total
cholesterol were seen to be lower in individuals born in African
countries than in those born in France. No differences were
observed for Gamma-Gt. Results observed in men and women
were very similar (data not shown). Compared to individuals
born in France, those who were born in Asia had lower brachial
and central PP, PP amplification, plasma cholesterol, and HDL-
cholesterol levels. In contrast, individuals born in Asia, were seen
to have higher brachial DBP,MBP levels, HR,WHR, triglycerides,
glycemia, and EPICES scores. Again, similar findings were
observed in both women and men (data not shown). Individuals
born in Asian countries had significantly lower brachial SBP,
DBP, brachial and central PP levels, PP amplification, CAI, HDL-
cholesterol, and BMI than those observed in individuals born
in African countries. In contrast, and despite lower BMI levels,
individuals born in Asia had higher HR, WHR, total cholesterol,
triglycerides, and glycemia compared with those born in Africa.
The proportion of study participants who were currently on
treatment for hypertension, diabetes, or plasma cholesterol are
shown in Table 2; it is noteworthy that the country of birth had
no effect on these parameters, as can be seen in Tables 3, 4.
Table 3 shows the characteristics of the study participants with
hypertension but without diabetes, according to country of birth.
When individuals born in France were compared with those
born in Africa, the results did not differ from those of the entire
population as shown inTable 2. When individuals born in France
and Asia were compared, the differences in brachial and central
PP, PP amplification and glycemia levels that were observed in
the overall population disappeared among hypertensive subjects.
Table 4 presents the characteristics of the study participants
(male and female) with both hypertension and diabetes,
according to country of birth. The main finding was that brachial
SBP, DBP, MBP, and HR did not differ between participants
who were born in Asia, Africa, or France, in contrast with the
results shown in Tables 2, 3. Brachial and central PP levels
were observed to be slightly higher in individuals born in
Africa than in those born in France. With regards to CAI,
and to a lesser extent PP amplification, results did not differ
from those in Tables 2, 3; this finding contrasted with the
results observed for brachial SBP, DBP, MBP, and HR. Because
individuals with both hypertension and diabetes tended to be
slightly older than those with hypertension alone, one could
hypothesize that age or presence of diabetes or both factors might
contribute to the particular disorders observed in the African
population.
Table 5 presents, for the three populations, the factors
associated with SBP variability as a function of country of birth.
Independently of age and DBP, only two parameters were shown
to be important considerations in each of the three populations:
gender and the degree of obesity or BMI. These findings were
independent of country of birth but differed in their extent.
For example, BMI was associated with 0.63, 0.32, and 0.83% of
SBP variability for individuals born in Asia, Africa, and France,
respectively.
Discussion
This study was conducted to assess the hemodynamic, metabolic
and arterial parameters of men and women living in France,
but according to their place of birth: Africa, Asia, or
France. The results focused on two frequently associated
populations: hypertensives and type 2 diabetics. Arterial values
were determined from standard hemodynamic and metabolic
measurements for both men and women, using classically
recognized calculations (Egan et al., 2010; Regnault et al.,
2012). Differences among such groups in terms of steady
BP, CV-risk profiles and pulsatile arterial hemodynamics (e.g.,
CAI and CPP/BPP ratio) became very apparent when the
country of birth “France” was compared to “Africa,” and
“Asia.”
One of the main limitations of our study was that we
were unable to specifically analyze race or ethnicity since
collecting these data is forbidden in France. Many people born
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TABLE 5 | Summary of Multiple Regression Models for study of SBP levels
according to country of birth in individuals born in Asia, Africa, and
France.
Parameter Partial R2 Cumulative R2 P
ASIA
1* DBP (mm Hg) 0.6270 0.6270 <0.0001
2 Age (years) 0.0185 0.6455 <0.0001
3 BMI (kg/m2) 0.0063 0.6518 <0.0001
4 Sex (M/F) 0.0048 0.6566 <0.0001
5 EPICES index 0.0006 0.6572 0.05
6 WHR 0.0006 0.6578 0.04
AFRICA
1 DBP (mm Hg) 0.6230 0.6230 <0.0001
2 Age (years) 0.0204 0.6434 <0.0001
3 Sex (M/F) 0.0096 0.6529 <0.0001
4 BMI (kg/m2) 0.0032 0.6561 <0.0001
5 Glycemia (mg/dL) 0.0010 0.6571 <0.0001
6 Smoking 0.0009 0.6580 <0.0001
7 EPICES index 0.0004 0.6584 0.0004
8 Cholesterol 0.0003 0.6587 0.0004
FRANCE
1 DBP (mm Hg) 0.5708 0.5708 <0.0001
2 Sex 0.0163 0.5871 <0.0001
3 BMI (kg/m2) 0.0083 0.5954 <0.0001
4 Age (years) 0.0069 0.6023 <0.0001
5 CAI 0.0012 0.6035 <0.0001
6 Glycemia (mg/dL) 0.0010 0.6045 <0.0001
7 EPICES index 0.0006 0.6052 <0.0001
8 Smoking 0.0009 0.6060 <0.0001
9 Triglycerides (mg/dL) 0.0003 0.6063 <0.0001
10 WHR 0.0002 0.6065 0.0004
Order is shown from 1 to 10.
DBP, diastolic blood pressure; BMI, body mass index; CAI, central augmentation index;
WHR, waist-hip ratio; EPICE score, Evaluation of Precariousness and Inequalities in Health
Examination Centers Score.
*Order in which the parameters were retained in the model.
in France are of black African or Asian descent. However, the
majority of African-born people living in France come from
North African countries and are not black. Furthermore, we
did not investigate confounding factors such as diet, which
are likely to differ between populations, particularly with
regards to salt, alcohol, and vegetable intake. Consequently,
based on the information available for this study, any wider
generalizations may only be suggested with caution, which
explains why this report is principally descriptive with statistical
estimates. Thus, from the data presented herein, we were
able to demonstrate significant associations between country
of birth and hemodynamic or metabolic parameters, but
not cause-and-effect relationships. Nevertheless, in a previous
report (Safar et al., 2013), we showed that 90% of our
study participants had the same country of birth as their
parents, suggesting similar genetic features according to country
of birth.
Most parameters recorded in African-born participants were
significantly higher than in participants born in France; total
cholesterol and HDL-cholesterol levels were however lower. The
same trend was observed for Asian-born participants, though
to a lesser extent and with the notable exception of SBP,
brachial and central PP, and PP amplification, which were lower.
Comparisons between Asian- and African-born participants
showed significantly higher HR, plasma triglycerides, total
cholesterol, glycemia, and WHR in Asian-born participants,
despite a lower BMI. It is important to note that these
results all affected the entire population regardless of gender,
the presence of normal or high BP levels, and/or diabetes
status.
In the present study, we evaluated the potential modulating
effects of two specific CV risk factors: hypertension and
type 2 diabetes. We found that, in baseline conditions,
steady hemodynamic factors such as brachial SBP, DBP, and
MBP as well as HR were significantly higher in African-
born individuals than in those born in France or Asia. This
observation persisted in individuals with hypertension as the
sole risk factor (Table 3) but disappeared when hypertension
was associated with diabetes (Table 4). In other words,
when hypertension and type 2 diabetes are associated, the
difference between “France” and “Africa” does not affect steady
hemodynamic parameters but rather pulsatile hemodynamics,
as was particularly manifest in the CAI and CPP/BPP ratio
calculations (Nichols and O’Rourke, 2006; Regnault et al., 2012;
Safar et al., 2013).
To understand the full implication of these results, it is
important to bear in mind the specific cumulative metabolic
burden of type 2 diabetes, fasting plasma glucose and fasting
insulin levels, dyslipidemia and metabolic syndrome. This leads
essentially to structural and functional arterial wall damage
chiefly via oxidative stress, inflammation and advanced glycation
end product (AGE) accumulation (Et-Taouil et al., 2003; Jonk
et al., 2007; Levy et al., 2008; Gingras et al., 2009). We and
others have already demonstrated that these factors are all related
to non-enzymatic protein glycation that forms irreversible, very
stiff cross-links in tissue proteins predominating in the large
artery wall, causing vascular calcification and altering their
structure and mechanical function (Et-Taouil et al., 2003; Jonk
et al., 2007; Levy et al., 2008; Gingras et al., 2009). Conversely,
insulin promotes capillary recruitment and may be associated
with dilatory as well as constrictive responses of resistance
arteries via endothelium-NO and endothelin release, respectively
(Jonk et al., 2007; Levy et al., 2008). These modifications
may well act on small and large arteries via several specific
pathways which are not those usually associated with the renin-
angiotensin or sympathetic nervous systems (Et-Taouil et al.,
2003; Jonk et al., 2007; Levy et al., 2008; Gingras et al.,
2009). Taken together, these pathways may well explain the
majority of the complex relationships that we observed in our
study population, particularly those relating to increased arterial
stiffness, which was significantly higher in diabetic than in non-
diabetic hypertensive individuals, for the same MBP (Safar et al.,
2013).
In the present investigation, it is important to note
that factors associated with SBP levels were determined in
a multifactorial investigation including successively France,
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Africa and Asia. In addition to age and DBP, two principal
parameters were defined as strong contributors to SBP variability:
obesity and gender. These two factors were consistently
noted as highly significant among the three categories of
our study participants born in France, Africa, or Asia.
These results concur with previous findings in the literature
indicating that the strongest predictors of BP control are
independently: body weight, BP, age, and possibly plasma
glucose control, but not dyslipidemia (Lloyd-Jones et al., 2000,
2002; Cushman et al., 2002; Dengo et al., 2010; Zhang et al.,
2013). Taken together, these findings suggest that a specific
strategy primarily involving body weight reduction should be
strongly recommended to improve BP control in hypertensive
individuals.
Conclusion and Perspectives
The present report has shown that origin of birth has a
notable impact on BP and CV risk profiles among French
residents. Individuals born in Africa are considerably
more likely than other populations to have a higher
brachial BP level. In contrast, individuals born in Asia
are more likely to have metabolic disorders with greater
glycemia, triglyceride and abdominal fat levels, as
determined by a larger waist circumference despite lower
BMI.
Country of birth is an appropriate parameter to assess
CV profiles, particularly in patients with both hypertension
and type 2 diabetes. In 2007, the European Societies of
Hypertension and Cardiology showed that arterial stiffness
may contribute to such CV profiles. First-line treatment
of patients with both hypertension and type 2 diabetes
should be based on pharmacological compounds that are
known to affect NO dysfunction, angiotensin and endothelin
blockade, as well as aortic stiffness and vascular rigidity,
as indicated above (Protogerou and Safar, 2007; Protogerou
et al., 2007; Sowers, 2013): in individuals with systolic
hypertension, because PP is increased, reduction of SBP
is useful and necessary while a too large reduction of
DBP may have resulting deleterious consequences. Finally,
in clinical practice, BP control should systematically include
assessment of the degree of obesity mass index. Thus, the
findings from this study highlight new perspectives for a




Country of birth is an appropriate parameter by which different
populations living in France in the same environment can be
studied to identify potential differences between individuals born
in France, in Asia or in Africa. Compared with people born
in France, the impact of country of birth on BP levels and
metabolic factors that influence CV risk is markedly greater in
individuals born in Africa and lower or identical in those born
in Asia. Findings such as these are observed more frequently
in populations with hypertension with or without simultaneous
type 2 diabetes as risk factors.
Results
In the population of study participants with hypertension alone,
those who were born in Africa were seen to have significantly
higher brachial blood pressure, HR, central and brachial pulse
pressure, and augmentation index and amplification levels as
compared with individuals born in France and in Asia. In people
with hypertension and diabetes mellitus, those born in Africa
did not have significantly elevated brachial BP and HR levels
but significantly elevated central and brachial pulse pressure,
augmentation index, and amplification levels were observed.
Regardless of the country of birth, alongside effective BP control,
appropriate assessment of body weight should be a mandatory
component of the management of all hypertensive patients.
Conclusion
The role of country of birth is a crucial factor in the choice
of antihypertensive therapy and the control of body weight in
hypertensive and diabetic populations, particularly when the
two CV risk factors occur simultaneously and involve pulsatile
arterial hemodynamic alterations. In individuals with systolic
hypertension, increased PP requires systolic BP to be reduced
whereas notable reductions in diastolic BP may have deleterious
consequences.
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